Improving clinical trial outcomes in amyotrophic lateral sclerosis

Individuals who are diagnosed with amyotrophic lateral sclerosis (ALS) today face the same historically intransigent problem that has existed since the initial description of the disease in the 1860s — a lack of effective therapies. In part, the development of new treatments has been hampered by an...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Nat Rev Neurol
Main Authors: Kiernan, Matthew C., Vucic, Steve, Talbot, Kevin, McDermott, Christopher J., Hardiman, Orla, Shefner, Jeremy M., Al-Chalabi, Ammar, Huynh, William, Cudkowicz, Merit, Talman, Paul, Van den Berg, Leonard H., Dharmadasa, Thanuja, Wicks, Paul, Reilly, Claire, Turner, Martin R.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2020
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7747476/
https://ncbi.nlm.nih.gov/pubmed/33340024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41582-020-00434-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki